TXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023

Date:

June 29, 2024

TherapeuticsMD (NASDAQ:TXMD) just reported results for the fourth quarter of 2023.

TherapeuticsMD reported earnings per share of -14 cents.
The company reported revenue of $502,000.

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Go Source

CRWS Stock Earnings: Crown Crafts Reported Results for Q4 2024

MRKR Stock Earnings: Marker Therapeutics Reported Results for Q4 2023